Navigation Links
The Medical Home: Building a Framework of Higher Quality, Reduced Cost and Patient-Centric Care
Date:2/6/2008

role of primary care physicians could mean short-term financial pain for hospitals and some health plans, and could aggravate the current manpower shortage without broadening the scope of ancillary providers' practice.

But the Center report, co-authored by Dr. Keckley and Dr. Howard R. Underwood of the Center, found that the long-range benefit is clear.

Pressure to adopt a medical home approach is driven by two critical, inter-connected factors - the shrinking number of primary care doctors due to difficult practice conditions and insufficient compensation, and the growing incidence/prevalence of chronic disease among the American population.

There is widespread recognition that the U.S. health care system falls short in its efforts to effectively manage chronic conditions, with some studies reporting care is sufficient only 55 percent of the time. Today, 45 percent of the population has a chronic medical condition. Among the Medicare population the statistics are even worse: 83 percent have at least one chronic condition and almost a quarter have at least five co-morbidities.

Related Content

Full Report: The Medical Home - Disruptive Innovation for a New Primary Care Model: http://www.deloitte.com/us/medicalhome

Overview: Deloitte Center for Health Solutions: http://www.deloitte.com/centerforhealthsolutions

Bio: Dr. Paul Keckley: http://www.deloitte.com/us/PaulKeckley

About Deloitte

As used in this document, "Deloitte" means Deloitte LLP, a subsidiary of Deloitte & Touche USA LLP. Please see http://www.deloitte.com/about for a detailed description of the legal structure of Deloitte & Touche USA LLP and its subsidiaries.
'/>"/>

SOURCE Deloitte
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Inverness Medical Innovations to Present at 2008 UBS Global Healthcare Services Conference on February 13, 2008
2. Dr. Inder Verma named recipient of 2008 Vilcek Prize in biomedical science
3. MarketResearch.com Distributes Key Findings on Global Specialty Medical Beds and Therapeutic Surfaces Market
4. Margaret Dimond Named President and CEO of McLaren Medical Management Inc.
5. Rising Medical Solutions, Inc. Ranks Fifth on the Private Company Index (PCI) Top Growth Companies List
6. Medical Cost Increases to Accelerate Worldwide Over Next Five Years, Watson Wyatt Poll Finds
7. Greenway Medical Technologies Continues Record Setting Growth
8. ReachMD and VerusMed Broadcast Medical Conference Coverage on XM Satellite Radio
9. Putting the Medical Profession on Notice!: Widow Tells Tragic Story of How Her Husband Died Due to Misdiagnosis and Mistreatment
10. SpringCM Improves Contract Management Efficiency for Medical Staffing Agency
11. Collaboration needed for strengthening medical research in Europe
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2008)...US, Ohio, Dec. 1 Seniors who take ...by Medicare Advantage plans may still realize,sav...y locations will continue,to offer $0 monthly pre...roughout the "gap" or "donut hole" (when beneficia...$4,350 in out-of-pocket costs). HealthMetrix,Res...
(Date:12/1/2008)...se cases, the implant makes it more difficult to t... MONDAY, Dec. 1 (HealthDay News) -- Women who have... later diagnosed with early-stage breast cancer ma...diation treatment known as brachytherapy, accordin...,s such a challenge to take care of these augmente...
(Date:12/1/2008)... American Board of Medical Spec...the certification of physician specialists in the ..., as the organization’s new chief operating ... EVANSTON, Ill. (Business Wire EON) Dec...xperience working in various industries including ...
(Date:12/1/2008)...nary CTA offers a low cost, non-invasive alternati...ents who are suspected of having coronary artery d...oronary artery plaques, according to a study perfo...Philadelphia, PA. , The study included 31 patien...laques that were discovered during coronary CTA. C...
Breaking Medicine News(10 mins):Health News:HealthMetrix Research Finds Medicare Advantage Plans Offer Seniors Opportunity to Lower Their 2009 Out-of-Pocket Drug Costs 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 2Health News:Radioactive 'Seed' Rx Helps Women With Implants Fight Breast Cancer 3Health News: ABMS Appoints Margaret Jung As New COO 2
...A patient lying in a vegetative state for over 3 y...ill, given to assuage a spell of restlessness//. T...clinical testing. Zolpidem, the name of this slee...n 30 patients during the course of this year, to c...
...Irritable bowel syndrome, by which 15% of American... habits and when medication doesn't help, there's .... Others like constipation, bloating, diarrhea and...ble, limiting some of their day-to-day activities....
...With the death toll rising to over 3500 and an inc...quake that measured 6.2 on scale, Indonesia strugg...uake hit the densely populated area in the south o... the southern coast of Java at 10.53PM late on the...
...A new survey has shown some alarming world statist..., which has indicated// that almost one in five 13...hese figures were made available in the run up to ...No Tobacco Day; on May 31st. This years theme will...
Other Medicine News:Health News:Silence Puts Comfort For Digestive Syndrome 2Health News:Indonesian Earthquake – Story of Destruction, Death and Disease 2
(Date:12/1/2008)...TING, Pa., Dec. 1 Genae...hat dosing of subjects has begun in study MSI-1436...se 1b study of trodusquemine (MSI-1436) in overwei...l therapeutic for the treatment of type 2 diabetes...y to regulate insulin and leptin pathways through ...
(Date:12/1/2008)...ec. 1 Vical Incorporated...a $1.0 million milestone payment from Merck & ... Phase I clinical trial of an investigational plas...ne is based on Vical,s DNA gene delivery technolog...se (hTERT). hTERT is the subject of separate licen...
(Date:11/28/2008)..., Nov. 28 Eli Lilly and ...ntal New Drug Application (sNDA) from,the U.S. Fo...duloxetine HCl),for the management of chronic pai... first half of 2009, adding data from a recently c... pain of the knee. , The decision does not ...
(Date:11/26/2008)...ed to 406 Subjects , , FRANKLIN, Mass., Nov...TC Bulletin Board: PLCSF) announced today that it ...Drug Administration (FDA) for its U.S. pivotal tri...alGuard System(TM) and associated therapy in the ..., , The FDA also approved PLC,s request to ...
Breaking Medicine Technology:Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 2Genaera Begins Phase 1b Trial of Trodusquemine (MSI-1436) in Overweight and Obese Type 2 Diabetics 3Vical Receives Milestone Payment from Merck & Co., Inc. Triggered by Planned Initiation of Investigational Cancer DNA Vaccine Trial 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 2Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 3Lilly Withdraws Application for Additional U.S. Indication for Cymbalta(R) for Chronic Pain 4PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 2PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 3PLC Systems Receives Full FDA Approval for Pivotal Study of RenalGuard(TM) in The U.S. 4Mylan Restores Availability of Generic Levothyroxine in Florida 11381 1Mylan Restores Availability of Generic Levothyroxine in Florida 11381 2Labopharm Reports Positive Results for Phase III Study on Once daily Trazodone 11376 1Labopharm Reports Positive Results for Phase III Study on Once daily Trazodone 11376 2Labopharm Reports Positive Results for Phase III Study on Once daily Trazodone 11376 3NHP Announces Fourth Quarter Earnings Release Date and Conference Call Webcast 11372 1NHP Announces Fourth Quarter Earnings Release Date and Conference Call Webcast 11372 2NHP Announces Fourth Quarter Earnings Release Date and Conference Call Webcast 11372 3Eat up all of your Brussels sprouts unless youre an aphid 2159 1Eat up all of your Brussels sprouts unless youre an aphid 2159 2
...-Apr 18, 2007 - Aeolus,Pharmaceuticals, Inc. (OTCB...d in the medical journal, Nature Genetics (Tong et...t Aeolus,Pharmaceuticals, lead compound AEOL 10150...etically lacking the neurofibromatosis-1,(NF1) gen...nction,and increased production of reactive oxygen...
...wire-FirstCall/ -- Helix,BioMedix, Inc. today anno...fficer, will present an update on the company,s ne...ptide) technology,at the BIO International Convent...Convention & Exhibition Center in Boston, MA f...is scheduled for,Wednesday, May 9th, Room D at 10:...
Other Medicine Technology:Aeolus Pharmaceuticals' AEOL 10150 Highlighted in Nature Genetics,Publication 2Aeolus Pharmaceuticals' AEOL 10150 Highlighted in Nature Genetics,Publication 3Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 2Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 3Helix BioMedix to Discuss Potential of Its Proprietary Peptides at,the BIO International Convention 4
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
...nce laboratory and a worldwide leader in innovativ... an extensive test menu of highly complex and uniq...y. Owned by the University of Utah, ARUP Laborator...s university teaching hospitals and children's hos...
Medicine Products: